Page results
-
Being diagnosed with cancer can be a difficult time for you and those close to you. This page gives you an overview of the care you can expect to receive as our patient at University College London Hospitals NHS Foundation Trust (UCLH). It also introduces different types of healthcare professionals you may meet along the way.
-
Information for UCLH patients requiring complex congenital gynaecology or with differences of sex development.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
Get expert pre-travel advice and vaccinations at The Hospital for Tropical Diseases Travel Clinic. Our specialists provide comprehensive care for travellers with complex medical conditions.
-
When the Lighthouse opened in 2018, it was the first establishment of its kind in the UK, offering a safe place for children and young people who have experienced sexual abuse.
-
About the RLHIM Pharmacy The RLHIM pharmacy is run by pharmacists who specialise in natural medicines, and it is both a hospital and a retail pharmacy. The RLHIM hospital pharmacy The…
-
We are a specialist Children and Young People's (CYP) Endocrinology Service. We also have access to the specialist adolescent psychology service, play specialists, and safeguarding team and are supported by a team of admin staff.
-
A programme of wellbeing classes, workshops and courses. It includes activities which give advice and/or support to help people to manage the physical and emotional impact of cancer or a blood condition.
File results
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care
-
FOI/2022/0233 - Diagnosis/ treatment of epilepsy, dravet syndrome, lennox gastaut syndrome and tuberous sclerosis complex